Results
Epidemiological aspectThe frequency: The vulva cancer is rare with 12 cases among 1234 about 1%.
Medium ageThe medium age during the diagnosis was 54 years with extreme of 22 and 84 years. 75% of women were olded than 55 years and menopause.
The socio-economic levelThe women have low socio-economic level married women 5% housewife 67% and multiparous 75%.
Clinical aspectsParity: 75% of vulva cancer was found in multiparous with a polygamy sexual regimen (Figure 1 We noted 1% of vulva cancer among the 1234 cases of Gynecological cancers diagnosed in the service. Two-third of the patients were elder than 55 years and the multiparous with 75%.The prurition and the tumefaction were the principal motive of consultation among 41.66 %.The tumor had epithelial origin in the clinical stage III in 50% of cases according to FIGO (2009). 3.6% of vulvectomy associated with lymphadenectomy in two-third and one case of radiotherapy.The cancers cases recorded were invasive epithelium type in old age women. These were intended to allow precocious diagnose and adequate taking care of the disease.
Mrs DAB, 33 years old, 4th gesture, and 4 living children, accountant, consults on 18/02/2018 for metrorrhagia on an amenorrhea of 3 months without precision of the date of the last period, with a history of dysmenorrhea, the last childbirth going back to 3 years without contraception. Upon gynecological examination, the cervix is intermediate, long and open to the finger pulp at the external orifice on a soft uterus, the size of 12 weeks-amenorrhea (AW) and a good general condition. The pelvic ultrasound performed with the trans-abdominal probe of 3.5Mhz, reveals, in intrauterine, a sluggish ovular sac having within it an inactive embryo whose value of the biometry
Objective: Describe the diagnosis, therapeutic and prognostic aspects of breast cancer and analyze the survival rate of patients.
Materials and methods:We conducted a quasi-retrospective descriptive and analytic study of 4 years from 1 st January 2010 to 31 st December 2013, folders of women histologically confirmed with breast cancer and consent was gotten through telephone contact. We described clinical and therapeutic characteristics, survival analyses was done using Epi-info 3.5, SPSS version 18 software with a significance level p<0.05 and survival by Kaplan Meier.Results: Breast cancer was confirmed in 12.62% with 3-month waiting time for histology result in clinically advanced stages (89.5%) and infiltrating ductal carcinoma (64.61%).Patients were aged 47.5 ± 8.5 years old, multiparous (66.69%), housewife (69.23%), uneducated (67.70%), referred (98.46%) and treated with chemotherapy for an overall survival of 23.07% at 5 years.
Conclusion:Infiltrating ductal carcinoma of the breast is frequent in the clinically advanced stage, treated with chemotherapy for uncertain survival at 5 years. Improving the survival and quality of life of women requires sensitization and training of women and health providers in breast palpation for early detection and treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.